polycythemia vera

Silence breaks down phase 1 data on blood disorder prospect, sharing glimpse at pitch for competitive niche
Fierce Biotech
Thu, 06/27/24 - 10:11 pm
Silence Therapeutics
polycythemia vera
clinical trial
siRNA
divesiran
FDA grants orphan drug designation for Disc’s PV treatment
Pharmaceutical Business Review
Mon, 02/12/24 - 11:45 am
Disc Medicine
DISC-3405
polycythemia vera
FDA
Takeda grabs late-stage hematology drug from Protagonist
Pharmaphorum
Thu, 02/1/24 - 11:20 am
Takeda
hematology
Protagonist Therapeutics
polycythemia vera
Agios and Alnylam sign agreement for siRNA candidate
Pharmaceutical Business Review
Fri, 08/4/23 - 12:09 pm
Agios Pharmaceuticals
Alnylam
siRNA
polycythemia vera
Blood cancer trial finds ruxolitinib better than current treatments
Clinical Trials Arena
Fri, 05/5/23 - 10:13 am
clinical trials
polycythemia vera
Jakafi
Incyte
PharmaEssentia's blood cancer treatment authorized in Europe
CP Wire
Thu, 02/23/23 - 04:21 pm
PharmaEssentia
Taiwan
polycythemia vera
ropeginterferon alfa
Europe
FDA approves PharmaEssentia interferon drug for a rare type of blood cancer
MedCity News
Mon, 11/15/21 - 11:44 pm
PharmaEssentia
FDA
interferon
blood cancers
polycythemia vera
ropeginterferon alfa
Incyte's Jakafi Gets FDA Approval for Polycythemia Vera
Yahoo/Zacks.com
Fri, 12/5/14 - 12:16 pm
Incyte
Jakafi
FDA
polycythemia vera
Incyte Gains on Positive Jakafi Data
Yahoo/Zacks.com
Wed, 06/4/14 - 02:53 pm
Incyte
Jakafi
polycythemia vera
ASCO
Novartis drug Jakavi seen as blockbuster after positive data
Yahoo/Reuters
Fri, 03/7/14 - 09:06 am
Novartis
Jakavi
polycythemia vera